Vera Therapeutics Inc. (VERA)
undefined
undefined%
At close: undefined
42.26
0.00%
After-hours Jan 06, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -95.99M -89.06M -32.61M -53.41M -11.85M
Depreciation & Amortization -4.09M -846.00K 176.00K 251.00K 509.00K
Stock-Based Compensation 11.49M 8.89M 3.01M 331.00K 263.00K
Other Working Capital -5.00M -3.86M 3.04M -444.00K 807.00K
Other Non-Cash Items 2.27M 6.67M 4.00M 16.71M 173.00K
Deferred Income Tax n/a n/a -1.80M 1.19M 104.00K
Change in Working Capital -5.87M 6.75M 3.51M 123.00K 516.00K
Operating Cash Flow -92.18M -67.60M -23.71M -34.81M -10.29M
Capital Expenditures -63.00K -62.00K n/a -99.00K -125.00K
Acquisitions n/a 70.49K 796.00K 57.00K n/a
Purchase of Investments -224.93M -148.49M n/a n/a n/a
Sales Maturities Of Investments 185.56M 78.00M n/a n/a n/a
Other Investing Acitivies n/a -70.49K -5.00M 57.00 n/a
Investing Cash Flow -39.43M -70.55M -4.20M -42.00K -125.00K
Debt Repayment 24.74M 19.82M 4.92M 5.47M -188.00K
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies -6.20M -4.01M -2.21M 79.82M 51.00K
Financial Cash Flow 133.54M 101.93M 53.88M 85.29M -137.00K
Net Cash Flow 1.93M -36.22M 25.97M 50.44M -10.55M
Free Cash Flow -92.24M -67.66M -23.71M -34.91M -10.41M